156 related articles for article (PubMed ID: 8490657)
1. Neurofibromatosis type 1 gene mutations in neuroblastoma.
The I; Murthy AE; Hannigan GE; Jacoby LB; Menon AG; Gusella JF; Bernards A
Nat Genet; 1993 Jan; 3(1):62-6. PubMed ID: 8490657
[TBL] [Abstract][Full Text] [Related]
2. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
[TBL] [Abstract][Full Text] [Related]
3. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors.
Guha A; Lau N; Huvar I; Gutmann D; Provias J; Pawson T; Boss G
Oncogene; 1996 Feb; 12(3):507-13. PubMed ID: 8637706
[TBL] [Abstract][Full Text] [Related]
4. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines.
Andersen LB; Fountain JW; Gutmann DH; Tarlé SA; Glover TW; Dracopoli NC; Housman DE; Collins FS
Nat Genet; 1993 Feb; 3(2):118-21. PubMed ID: 8499944
[TBL] [Abstract][Full Text] [Related]
6. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
Hattori S; Maekawa M; Nakamura S
Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
[TBL] [Abstract][Full Text] [Related]
7. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.
Gutmann DH; Giordano MJ; Mahadeo DK; Lau N; Silbergeld D; Guha A
Oncogene; 1996 May; 12(10):2121-7. PubMed ID: 8668337
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.
Gutmann DH; Boguski M; Marchuk D; Wigler M; Collins FS; Ballester R
Oncogene; 1993 Mar; 8(3):761-9. PubMed ID: 8437860
[TBL] [Abstract][Full Text] [Related]
9. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
Stang S; Bottorff D; Stone JC
Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
[TBL] [Abstract][Full Text] [Related]
10. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.
Kim HA; Rosenbaum T; Marchionni MA; Ratner N; DeClue JE
Oncogene; 1995 Jul; 11(2):325-35. PubMed ID: 7624147
[TBL] [Abstract][Full Text] [Related]
11. Modulation of neurofibromatosis type 1 gene expression during in vitro myoblast differentiation.
Gutmann DH; Cole JL; Collins FS
J Neurosci Res; 1994 Feb; 37(3):398-405. PubMed ID: 8176761
[TBL] [Abstract][Full Text] [Related]
12. Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene.
Li Y; White R
Cancer Res; 1996 Jun; 56(12):2872-6. PubMed ID: 8665528
[TBL] [Abstract][Full Text] [Related]
13. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
Weiss B; Bollag G; Shannon K
Am J Med Genet; 1999 Mar; 89(1):14-22. PubMed ID: 10469432
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
Marshall MS; Hettich LA
Oncogene; 1993 Feb; 8(2):425-31. PubMed ID: 8426748
[TBL] [Abstract][Full Text] [Related]
15. Stimulus-evoked release of neuropeptides is enhanced in sensory neurons from mice with a heterozygous mutation of the Nf1 gene.
Hingtgen CM; Roy SL; Clapp DW
Neuroscience; 2006; 137(2):637-45. PubMed ID: 16298082
[TBL] [Abstract][Full Text] [Related]
16. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
Bollag G; Clapp DW; Shih S; Adler F; Zhang YY; Thompson P; Lange BJ; Freedman MH; McCormick F; Jacks T; Shannon K
Nat Genet; 1996 Feb; 12(2):144-8. PubMed ID: 8563751
[TBL] [Abstract][Full Text] [Related]
17. [Molecular-genetic aspects of neurofibromatosis].
Hulsebos TJ
Ned Tijdschr Geneeskd; 1997 Mar; 141(13):620-3. PubMed ID: 9190537
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation.
Nishi T; Lee PS; Oka K; Levin VA; Tanase S; Morino Y; Saya H
Oncogene; 1991 Sep; 6(9):1555-9. PubMed ID: 1923522
[TBL] [Abstract][Full Text] [Related]
19. Analysis of NF1 gene mutations in neurofibromatosis type 1 patients in Japan.
Hatta N; Horiuchi T; Fujita S
Biochem Biophys Res Commun; 1994 Feb; 199(1):207-12. PubMed ID: 8123014
[TBL] [Abstract][Full Text] [Related]
20. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.
Basu TN; Gutmann DH; Fletcher JA; Glover TW; Collins FS; Downward J
Nature; 1992 Apr; 356(6371):713-5. PubMed ID: 1570015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]